• Western blot analysis of extracts of various cell lines, using ENDOGL1/ENGL antibody (STJ11104092) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) (STJS000856) at 1:10000 dilution. Lysates/proteins: 25 Mu g per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 90s.

Anti-EXOG antibody (269-368) [S4092RM] (STJ11104092)

SKU:
STJ11104092

Shipping:
Free Shipping
Current Stock:
Host: Rabbit
Applications: WB
Reactivity: Human
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit monoclonal antibody anti-Nuclease Exog-Mitochondrial (269-368) is suitable for use in Western Blot research applications.
Clonality: Monoclonal
Clone ID: S4092RM
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.02% Sodium Azide, 0.05% BSA, 50% Glycerol, pH7.3.
Purification: Affinity purification
Dilution Range: WB 1:500-1:1000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: EXOG
Gene ID: 9941
Uniprot ID: EXOG_HUMAN
Immunogen Region: 269-368
Immunogen: A synthetic peptide corresponding to a sequence within amino acids 269-368 of human ENDOGL1/ENGL (Q9Y2C4).
Immunogen Sequence: LQDLEKLSGLVFFPHLDRTS DIRNICSVDTCKLLDFQEFT LYLSTRKIEGARSVLRLEKI MENLKNAEIEPDDYFMSRYE KKLEELKAKEQSGTQIRKPS
Tissue Specificity Ubiquitous.
Function Endo/exonuclease with nicking activity towards supercoiled DNA, a preference for single-stranded DNA and 5'-3' exonuclease activity.
Protein Name Nuclease Exog - Mitochondrial
Endonuclease G-Like 1
Endo G-Like 1
Cellular Localisation Mitochondrion Inner Membrane
Alternative Antibody Names Anti-Nuclease Exog - Mitochondrial antibody
Anti-Endonuclease G-Like 1 antibody
Anti-Endo G-Like 1 antibody
Anti-EXOG antibody
Anti-ENDOGL1 antibody
Anti-ENDOGL2 antibody
Anti-ENGL antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance